Pricing

Simple, predictable economics.

Traditional infrared VNG / video goggles can represent a significant capital expense. SmartVertigo™ replaces that model with a one-time hardware cost and volume-indexed subscription tiers, scaled to your clinic’s throughput.

Subscription

One hardware cost. Three subscription tiers.

Tiers are designed to align cost with your actual patient volume — not punitive per-test fees. Final pricing will be published at FDA clearance.

Essentials
For solo practices
Up to 10 patients / month
Pricing — TBD, at FDA clearance
Solo primary-care, chiropractic, and lower-volume PT or audiology practices establishing a vestibular workflow.
High-Volume
For EDs & specialty
20+ patients / month
Pricing — TBD, at FDA clearance
Hospital emergency departments and high-volume vestibular specialty clinics where speed and documentation matter most.
A different equation

The old model vs. SmartVertigo™.

SmartVertigo™ uses a smartphone you already own, replaces six-figure capital with a subscription, and scales across sites without rebuilding a vestibular lab in each one.

Traditional infrared VNG / video goggles

  • Six-figure capital outlay for infrared VNG / video goggles
  • Dedicated darkroom or fixed exam space
  • A trained vestibular technician often required
  • Lengthy setup, cabling, and patient positioning
  • Service contracts and calibration overhead
  • Throughput capped by a single physical location

SmartVertigo™

  • Flat hardware cost plus a volume-indexed subscription
  • Any exam room — no darkroom needed
  • Operable by any trained clinician in the practice
  • Single-operator, out of the case in seconds
  • Over-the-air app updates, no service contracts
  • Scales across sites with additional headsets
Market context

Why the economics matter.

$2BSpent every year in the U.S. on diagnosing BPPV alone.
~$2,000Average cost to reach a single BPPV diagnosis under the current model.
65%+Of BPPV patients undergo potentially unnecessary testing or treatment.

Market-context figures per the American Academy of Otolaryngology–Head and Neck Surgery Foundation, Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update), 2017. Illustrative of the wider market; not a claim about outcomes with SmartVertigo™.

Get in Touch

Bring the vestibular lab to your point of care.

Request a demo, ask a clinical question, or explore enterprise and federal licensing. Our team responds within one business day.